Water

Water

SCHEMBL365214

NC(O)(Cl)CCc1ccccc1.O

nearest known ligand 0.43

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABCC9ABL1ACEACHEACVR1ADORA1ADORA2AADORA2BADORA3ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALOX5ATP4AATP4BBCRBTKCACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGCRBNCUL4ACXCR1CXCR2DDB1DDCDHFRDPP4DRD2DRD3DRD4EGFRERBB2ERBB4ESR1ESR2FDPSFKBP1AFLT1FLT3FLT4GARTGHSRGRIA1GRIA2GRIA3GRIA4GRIK1GRIK2GRIK3GRIK4GRIK5GRIN2AGSK3AGSK3BHDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IDH1IDH2IMPA1ITGA2BITGB3JAK1JAK2JAK3KCNJ11KCNK3KCNK9KDRKITMEN1METMMP1MMP13MMP7MMP8NANOD2NS5bODC1OPG057OPRD1OPRK1OPRM1PPARP1PARP2PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDGFRBPIK3CAPIK3CBPIK3CDPIK3CGPIK3R1PIK3R2PIK3R3PIK3R5PKLRPPARDPPATPTGS1PTGS2RBX1ROCK1ROCK2RRM1RRM2RRM2BSCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC10A2SLC5A2SLC6A2SLC6A3SLC6A4SLC9A3SYKTACR1THRATHRBTOP1TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYK2TYMSVDRampCblablaT-3blaT-4blaT-5blaT-6blaUOE-1dacAdacBdacCfolAfolPftsIgyrAgyrBileSmecAmrcAmrcBmrdAparCparEpbp2pbp4pbpApbpFrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUthyAykgMykgO

The experimentally established mechanism targets of Water. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2A known ✓ P28223 1/20 0.43
SLC6A2 known ✓ P23975 2/20 0.39
HTR1A known ✓ P08908 1/20 0.39
ADRA2A known ✓ P08913 1/20 0.39
PTGS1 known ✓ P23219 1/20 0.39
ADRA1A known ✓ P35348 1/20 0.39
HTR3A known ✓ P46098 1/20 0.38
SMN1; SMN2 Q16637 3/20 0.43
TAAR1 Q96RJ0 2/20 0.43
TDP1 Q9NUW8 2/20 0.43
CYP2A6 P11509 1/20 0.43
LOXL2 Q9Y4K0 1/20 0.43
GRM2 Q14416 1/20 0.42
GRM3 Q14832 1/20 0.42
MAOA P21397 4/20 0.40
MAOB P27338 4/20 0.40
HIF1A Q16665 1/20 0.39
ALDH1A1 P00352 2/20 0.39
HPGD P15428 1/20 0.39
ALOX15 P16050 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6809935 0.98 SMN1; SMN2 (0.44) SMN1; SMN2TAAR1TDP1CYP2A6HTR2A
SCHEMBL28681602 0.80 SMN1; SMN2 (0.48) SMN1; SMN2TAAR1TDP1CYP2A6HTR2A
SCHEMBL5003745 0.80 TAAR1 (0.48) SMN1; SMN2TAAR1TDP1CYP2A6HTR2A
Hydrochloric Acid SCHEMBL8670716 0.78 MAOB (0.46) SMN1; SMN2TAAR1TDP1CYP2A6HTR2A
SCHEMBL3367528 0.77 TAAR1 (0.50) SMN1; SMN2TAAR1TDP1CYP2A6HTR2A
SCHEMBL7776472 0.77 SMN1; SMN2 (0.44) SMN1; SMN2TAAR1TDP1CYP2A6HTR2A
SCHEMBL27498335 0.76 SMN1; SMN2 (0.42) SMN1; SMN2TAAR1TDP1CYP2A6HTR2A
SCHEMBL2778837 0.75 SMN1; SMN2 (0.48) SMN1; SMN2TAAR1TDP1CYP2A6HTR2A
SCHEMBL8375787 0.75 CYP1A2 (0.47) SMN1; SMN2TAAR1TDP1CYP2A6HTR2A
SCHEMBL7196259 0.75 TDP1 (0.52) SMN1; SMN2TAAR1TDP1CYP2A6HTR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2512516-B1 INJECTABLE POLYMER COMPOSITION FOR USE AS A CELL DELIVERY VEHICLE UNIV TORONTO (CA) 2016-02-17 EP claimed
EP-2806034-B1 Compounds and uses thereof to induce an immunogenic cancer cell death in a subject ROUSSY INST GUSTAVE (FR) 2017-06-28 EP disclosed
EP-2806034-A1 Compounds and uses thereof to induce an immunogenic cancer cell death in a subject Institut Gustave Roussy (FR) 2014-11-26 EP disclosed
US-8865653-B2 Method of treatment for immunogenic treatment resistant cancer INSTITUT GUSTAVE ROUSSY (FR) 2014-10-21 US disclosed
US-8828944-B2 Compounds and uses thereof to induce an immunogenic cancer cell death in a subject INSTITUT GUSTAVE ROUSSY (FR) 2014-09-09 US disclosed
US-20130156790-A1 COMPOUNDS AND USES THEREOF TO INDUCE AN IMMUNOGENIC CANCER CELL DEATH IN A SUBJECT INSTITUT GUSTAVE ROUSSY (FR) 2013-06-20 US disclosed
US-20130052160-A1 COMPOUNDS AND USES THEREOF TO INDUCE AN IMMUNOGENIC CANCER CELL DEATH IN A SUBJECT INSTITUT GUSTAVE ROUSSY (FR) 2013-02-28 US disclosed
EP-2561088-A1 COMPOUNDS AND USES THEREOF TO INDUCE AN IMMUNOGENIC CANCER CELL DEATH IN A SUBJECT Institut Gustave Roussy (FR) 2013-02-27 EP disclosed
WO-2012007783-A1 KITS AND METHODS FOR DETECTING THE ABILITY TO INDUCE AN IMMUNOGENIC CANCER CELL DEATH IN A SUBJECT INSTITUT GUSTAVE ROUSSY (FR) 2012-01-19 WO disclosed
WO-2011131472-A1 COMPOUNDS AND USES THEREOF TO INDUCE AN IMMUNOGENIC CANCER CELL DEATH IN A SUBJECT INSTITUT GUSTAVE ROUSSY (FR) 2011-10-27 WO disclosed
WO-2011131246-A1 COMPOUNDS AND USES THEREOF TO INDUCE AN IMMUNOGENIC CANCER CELL DEATH IN A SUBJECT INSTITUT GUSTAVE ROUSSY (FR) 2011-10-27 WO disclosed